Literature DB >> 16707383

Myeloid sarcoma involving the gynecologic tract: a report of 11 cases and review of the literature.

Mar Garcia Garcia1, Michael T Deavers, Ronald J Knoblock, Weina Chen, Apostolia M Tsimberidou, John T Manning, L Jeffrey Medeiros.   

Abstract

Myeloid sarcoma can involve any anatomic site, but involvement of the gynecologic tract is uncommon. We describe 11 women, 17 to 60 years old, with myeloid sarcoma involving the gynecologic tract, including 5 patients in whom myeloid sarcoma presented as an isolated mass. The uterus was the most frequently involved anatomic site, in 8 patients (5 corpus, 3 cervix). Each neoplasm diffusely infiltrated normal structures, and, cytologically 7 tumors were immature, 3 were differentiated, and 1 was blastic. In 9 cases assessed, immunohistochemical stains showed that all neoplasms were positive for myeloperoxidase and lysozyme; CD117 was positive in 7 of 8 cases, and cytochemical staining for naphthol AS-D chloroacetate was positive in all 6 neoplasms analyzed. Following chemotherapy, complete remission and long-term survival were achieved in a subset of patients, as was particularly true for 2 patients (cases 8 and 10), with complete remission 12.5 and 31 years after diagnosis, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707383     DOI: 10.1309/H9MM-21FP-T7YB-L3PW

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  15 in total

1.  Giant granulocytic sarcoma of the vagina concurrent with acute myeloid leukemia with t(8;21)(q22;q22) translocation.

Authors:  Jun Imagawa; Yuka Harada; Tetsumi Yoshida; Akira Sakai; Naomi Sasaki; Akiro Kimura; Hironori Harada
Journal:  Int J Hematol       Date:  2010-09-10       Impact factor: 2.490

2.  A rare case of acute leukemia relapsing with a granulocytic sarcoma causing ectopic pregnancy.

Authors:  Merve Pamukçuoğlu; Kadir Acar; Nalan Akyürek; Gülsan Türköz Sucak
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

3.  An unusual relapse in acute myeloid leukaemia.

Authors:  Feras Abu Saadeh; Vicki Collins; Maimuna Al-Saadi; Noreen Gleeson
Journal:  BMJ Case Rep       Date:  2015-02-20

4.  Myeloid Sarcoma of the Uterine Cervix as Presentation of Acute Myeloid Leukaemia after Treatment with Low-Dose Radioiodine for Thyroid Cancer: A Case Report and Review of the Literature.

Authors:  Anne Sophie Weingertner; Marc Wilt; Ihab Atallah; Cécile Fohrer; Laurent Mauvieux; Jean-François Rodier
Journal:  Case Rep Oncol       Date:  2009-01-17

Review 5.  Postmenopausal bleeding as first sign of an acute myelogenous leukaemia: A case report and review of the literature.

Authors:  M Henes; A Nauth; A Staebler; S Becker; J C Henes
Journal:  Med Oncol       Date:  2009-09-10       Impact factor: 3.064

6.  Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement.

Authors:  Stephan Zaenker; Stefan Schweyer; Justin Hasenkamp; Lorenz Truemper; Gerald Wulf
Journal:  Case Rep Hematol       Date:  2011-09-05

7.  Granulocytic Sarcoma of the Uterus: A Rare Presentation of Extramedullary Relapse of AML and Importance of MRI.

Authors:  Murat Ucar; Melike Guryildirim
Journal:  Case Rep Radiol       Date:  2014-12-30

8.  Aleukemic granulocytic sarcoma presenting at multiple sites: ovary, breast and soft tissue.

Authors:  Jitendra Singh Nigam; Vatsala Misra; Varsha Kumar; Kachnar Varma
Journal:  Rare Tumors       Date:  2012-06-26

9.  Myeloid sarcoma of the uterine cervix presenting as missed abortion.

Authors:  Harinder Gill; Florence Loong; Vivien Mak; Karen Chan; Wing-Yan Au; Yok-Lam Kwong
Journal:  Arch Gynecol Obstet       Date:  2012-07-12       Impact factor: 2.344

10.  Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study.

Authors:  Borislav A Alexiev; Wenle Wang; Yi Ning; Saranya Chumsri; Ivana Gojo; William H Rodgers; Sanford A Stass; Xianfeng F Zhao
Journal:  Diagn Pathol       Date:  2007-10-31       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.